Search Results - "Barkham, Nick"

Refine Results
  1. 1

    Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with ankylosing spondylitis during the coronavirus disease (COVID‐19) pandemic: A case series by Vijayan, Sooraj, Hwangbo, Kyungmin, Barkham, Nick

    Published in Clinical case reports (01-01-2022)
    “…The COVID‐19 pandemic emphasized the utility of subcutaneous (SC) biologics for pressured healthcare systems. The first SC form of infliximab, CT‐P13 SC,…”
    Get full text
    Journal Article
  2. 2

    Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID‐19) pandemic: A case series by Baraliakos, Xenofon, Tsiami, Styliani, Vijayan, Sooraj, Jung, Haewon, Barkham, Nick

    Published in Clinical case reports (01-01-2022)
    “…The COVID‐19 pandemic highlighted the benefits of subcutaneous (SC) administration for healthcare systems. The first SC infliximab, CT‐P13 SC, was safe and…”
    Get full text
    Journal Article
  3. 3

    Statin‐induced autoimmune necrotizing myositis—A single‐center case series highlighting this potentially life‐threatening but treatable condition by Jasim, Muhamad, Sapkota, Hem, Timmons, Margaret, Manfredonia, Francesco, Pohl, Ute, Barkham, Nick

    Published in Clinical case reports (01-12-2020)
    “…Statin‐induced autoimmune necrotizing myositis is a rare but important cause muscle weakness. Withdrawal of the statin and steroid treatment alone may be…”
    Get full text
    Journal Article
  4. 4

    Reducing work disability in Ankylosing Spondylitis: development of a work instability scale for AS by Gilworth, Gill, Emery, Paul, Barkham, Nick, Smyth, M Glyn, Helliwell, Philip, Tennant, Alan

    Published in BMC musculoskeletal disorders (16-06-2009)
    “…The Work Instability Scale for Rheumatoid Arthritis (RA-WIS) is established and is used by physicians to identify patients at risk of job loss for rapid…”
    Get full text
    Journal Article
  5. 5

    The current standard of care and the unmet needs for axial spondyloarthritis by Noureldin, Basil, Barkham, Nick

    Published in Rheumatology (Oxford, England) (01-11-2018)
    “…Abstract The aim of this article is to explore the benefits and limitations of the established treatments for axial SpA (axSpA), including physiotherapy,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    P015 Improving the diagnostic performance of ANCA testing: evaluating the use of a gating strategy for ANCA test requests by Cleaton, Natasha, Barkham, Nick, Adizie, Tochukwu

    Published in Rheumatology (Oxford, England) (25-04-2021)
    “…Abstract Background/Aims  Anti-neutrophil cytoplasmic antibody (ANCAs) associated vasculitis (AAV) encompasses: Granulomatosis with polyangiitis (GPA),…”
    Get full text
    Journal Article
  9. 9

    P181 Detection of anti-neutrophil cytoplasmic antibodies: a single-centre evaluation of the value of indirect immunofluorescence versus antigen-specific immunoassays by Cleaton, Natasha, Adizie, Tochukwu, Barkham, Nick

    Published in Rheumatology (Oxford, England) (01-04-2020)
    “…Abstract Background Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for the diagnosis of medium and small-vessel…”
    Get full text
    Journal Article
  10. 10

    P075 Long COVID is associated with poor mental health in patients with rheumatic disease: results from a 14-month longitudinal study by Cox, Natasha, Raizada, Sabrina R, Barkham, Nick, Bateman, James

    Published in Rheumatology (Oxford, England) (23-04-2022)
    “…Abstract Background/Aims COVID-19 has had severe consequences across the globe and the detrimental impacts are continually emerging. Recently it has been…”
    Get full text
    Journal Article
  11. 11

    P198 Efficacy and safety of secukinumab in ankylosing spondylitis: real-world data from Midlands Ankylosing Spondylitis Collaboration (MASC) by Jain, Nibha, Laxminarayan, Ramasharan, Moorthy, Arumugam, Amarasena, Roshan, Cleaton, Natasha, Kakade, Girish, Gunawardane, Aloka, Khan, Tahir, Sapkota, Hem, Barkham, Nick

    Published in Rheumatology (Oxford, England) (25-04-2021)
    “…Abstract Background/Aims  Secukinumab is an interleukin-17 inhibitor has been found to be effective in the treatment of ankylosing spondylitis (AS) in studies,…”
    Get full text
    Journal Article
  12. 12

    52. Not every rheumatologic headache is giant cell arteritis: a case of aseptic meningitis on a background of rheumatoid arthritis by Magan, Priyan, Jasim, Muhamad, Barkham, Nick

    Published in Rheumatology advances in practice (26-09-2019)
    “…Abstract Introduction A 65-year-old Caucasian lady had a background of longstanding seropositive rheumatoid arthritis (RA) for which multiple disease modifying…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis by Barkham, Nick, Coates, Laura C, Keen, Helen, Hensor, Elizabeth, Fraser, Alexander, Redmond, Anthony, Cawkwell, Lorna, Emery, Paul

    Published in Annals of the rheumatic diseases (01-11-2010)
    “…Etanercept has been shown to be rapidly effective in suppressing disease activity in ankylosing spondylitis (AS). The aim of this study was to determine…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Are telephone consultations here to stay in rheumatology? by Raizada, Sabrina R, Cleaton, Natasha, Bateman, James, Mulherin, Diarmuid M, Barkham, Nick

    Published in Rheumatology advances in practice (01-01-2021)
    “…Abstract Objectives During the COVID-19 pandemic, face-to-face rheumatology follow-up appointments were mostly replaced with telephone or virtual consultations…”
    Get full text
    Journal Article
  20. 20